Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma. [electronic resource]
Producer: 20180831Description: 296 p. digitalISSN:- 1471-2407
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.